Allos Therapeutics Inc. (ALTH) surged 27 percent to $1.82. The biopharmaceutical company agreed to be bought by Spectrum Pharmaceuticals Inc. (SPPI) for $1.82 a share, plus rights worth 11 cents a share tied to European regulatory approval and sales of its Folotyn cancer drug. Spectrum declined 14 percent to $10.40.
AngioDynamics Inc. (ANGO) : The maker of devices to treat cancer and heart disease forecast fourth-quarter earnings may be as low as 9 cents a share, compared with the average analyst estimate of 11 cents.
Bed Bath & Beyond Inc. (BBBY) rose 4.6 percent to $69.28. The retail-chain operator posted a fourth-quarter profit of $1.48 a share, beating the average analyst estimate of $1.32.
Galena Biopharma Inc. (GALE) slid 16 percent to $1.57. The developer of late-stage oncology drugs said it plans to sell stock to raise working capital and fund clinical trials.
Pandora Media Inc. (P) : The Internet radio pioneer is in a pact with Nissan Motor Co. (7201)(7201 JP) to allow for in-car streaming in the auto company’s 2013 Altima. Suzuki Motor Corp. (7269) (7269 JP) will also integrate Pandora into its vehicles.
Polycom Inc. (PLCM) dropped 16 percent to $10.47. The maker of videoconference systems forecast first-quarter earnings of 23 cents a share at most, missing the average analyst estimate of 30 cents a share.
PriceSmart Inc. (PSMT) : The owner of warehouse-shopping clubs reported second-quarter earnings were 67 cents a share, trailing analysts’ average estimate by 1 cent.
Ruby Tuesday Inc. (RT) slid 12 percent to $7.85. The casual-dining chain forecast same store sales may fall 4.5 percent in 2012.
Zumiez Inc. (ZUMZ) : The sports-apparel retailer said comparable store sales increased 14 percent in March, exceeding the average analyst estimate of 10 percent.
Comments »